Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • patient outcomes

    - PMLiVE

    Game On: Medscape Education Golfs for a Cause

    Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...

    Medscape Education

    - PMLiVE

    Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

    UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

    Medscape Education

    - PMLiVE

    Medscape Cardiology: Leading the Future of Heart Failure Education at HFSA 2025

    Medscape Cardiology | theheart.org is proud to be at the forefront of the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM), September 26–29, 2025, in Minneapolis, MN! With...

    Medscape Education

    - PMLiVE

    FDA approves Apellis’ Empaveli for two rare kidney diseases

    C3G and primary IC-MPGN are estimated to affect 5,000 people in the US

    - PMLiVE

    Sobi/Apellis’ pegcetacoplan shows sustained efficacy in phase 3 kidney disease study

    C3G and primary IC-MPGN are estimated to affect 5,000 people in the US and up to 8,000 in Europe

    - PMLiVE

    Otsuka shares promising phase 3 results for sibeprenlimab in rare kidney disease IgAN

    The trial will continue to evaluate change in kidney function over two years

    - PMLiVE

    Medscape Celebrates Eight Groundbreaking Publications at ATS 2025 International Conference

    Medscape Education is proud to announce the presentation of eight innovative educational research publications at the American Thoracic Society (ATS) 2025 International Conference, held May 16–21 in San Francisco, CA....

    Medscape Education

    - PMLiVE

    Medscape Women’s Health Joins Supporters in Sponsorship of SWHR’s 2025 Gala

    Medscape Women’s Health is proud to announce its sponsorship of the Society for Women's Health Research (SWHR) 2025 Gala, which took place on Wednesday, April 30, 2025, celebrating 35 Years...

    Medscape Education

    - PMLiVE

    Looking Ahead: Transparency, Impact, and Instructional Design at CMEpalooza Spring 2025

    Tomorrow at 2 PM ET, join Medscape for a thought-provoking Afternoon Snack Session at CMEpalooza Spring 2025, titled “Reverse Planning with Forward Thinking.” This session will spotlight how clear communication...

    Medscape Education

    - PMLiVE

    Novartis’ Fabhalta granted FDA approval to treat ultra-rare kidney disease C3G

    Approximately half of C3G patients progress to kidney failure within ten years of diagnosis

    - PMLiVE

    Medscape at ACC 2025: From Taking the Pulse to Getting to the Heart of It

    The Medscape team is back in Chicago for the much-anticipated ACC 2025 conference,  March 29-31, bringing an array of engaging educational booth highlights, interactive symposia, scientific posters, and more for...

    Medscape Education

    Biogen Idec building

    Biogen initiates phase 3 study of felzartamab in kidney transplant patients

    The trial will evaluate the candidate in patients with antibody-mediated rejection

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links